Vaccine News and Research

Latest Vaccine News and Research

Scientists detect emergence and spread of artemisinin-resistant malaria parasites in Rwanda

Resistance to artemisinin, the main component of the current antimalarial treatments recommended by WHO, is already widespread in South-East Asia, but it had not previously been described in Africa.

5 Aug 2020

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

Now, Regeneron Pharmaceuticals says its COVID-19 antibody-drug cocktail under development prevented and treated the disease in monkeys and hamsters, showing promise that it may work in humans.

5 Aug 2020

Study: "Memory" T cells that recognize common cold coronaviruses also recognize SARS-CoV-2

Your immune system's "memory" T cells keep track of the viruses they have seen before. This immune cell memory gives the cells a headstart in recognizing and fighting off repeat invaders.

5 Aug 2020

Dire COVID-19 warning from World Health Organization

The coronavirus pandemic (COVID-19) has swept across the globe, infecting more than 18 million people. With the rapid spread of the virus, the World Health Organization (WHO) warns that there might never be a “silver bullet” to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

5 Aug 2020

New computational model can help determine drug viability

About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn's disease, end up becoming resistant or unresponsive to it.

5 Aug 2020

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, which will be conducted by the ACTG.

4 Aug 2020

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease.

4 Aug 2020

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.

4 Aug 2020

Yale researchers develop new mouse model to study SARS-CoV-2 infection

Researchers at Yale University School of Medicine have developed a new mouse model to study SARS-CoV-2 infection and disease and to accelerate testing of novel treatments and vaccines against the novel coronavirus.

4 Aug 2020

Illustrating the dystopic nature of people’s approach to COVID-19

Are we "Waiting for Godot"- A Metaphor for Covid-19 "Waiting for Godot", one of the greatest works of the Theater of the Absurd is used to illustrate the dystopic nature of our approach to COVID-19.

4 Aug 2020

Study identifies possible therapeutic treatment for COVID-19

Yunjeong Kim and Kyeong-Ok "KC" Chang, virologists in the College of Veterinary Medicine at Kansas State University, have published a study showing a possible therapeutic treatment for COVID-19.

3 Aug 2020

Extensive study of SARS-CoV-2 sequencing reveals six strains of the virus

The virus causing the COVID-19 pandemic, SARS-CoV-2, presents at least six strains. Despite its mutations, the virus shows little variability, and this is good news for the researchers working on a viable vaccine.

3 Aug 2020

Oxford University and ZOE join forces to widen access to COVID-19 treatment trials

Oxford University and the COVID Symptom Study app are joining forces to widen access to two clinical trials of potential treatments for COVID-19.

3 Aug 2020

Maternal vaccination could protect infants against RSV illness

Immunizing pregnant women with a potential vaccine against RSV could prevent the most common cause of pneumonia in their babies.

3 Aug 2020

What seniors can expect as their new normal in a post-vaccine world

Imagine this scenario, perhaps a year or two in the future: An effective COVID-19 vaccine is routinely available and the world is moving forward. Life, however, will likely never be the same — particularly for people over 60.

3 Aug 2020

Meningitis case at Children's National Hospital raises concerns about antibiotic resistance

A recent meningitis case at Children's National Hospital raises serious concerns about antibiotic resistance in the common bacterium that caused it, researchers from the hospital write in a case report.

3 Aug 2020

Stabilized prefusion spike vaccine candidate induces powerful immune response

A new research paper by scientists at Janssen Vaccines & Prevention BV, in the Netherlands and published on the preprint server bioRxiv* is based on the assumption that an effective vaccine against these infections will induce neutralizing antibodies and an immune response favoring Th1 immunity.

3 Aug 2020

The race to a coronavirus vaccine

As the number of coronavirus disease (COVID-19) cases skyrocket to a staggering 18 million, the race to attain vaccine approval is on. More than a hundred candidate vaccines are being developed and tested to prevent infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, many vaccine candidates are undergoing human stage 2 and 3 trials to prove their efficacy and safety.

2 Aug 2020

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

In a groundbreaking bioRxiv study, US researchers demonstrate the capability of next-generation bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – using both an S protein sequence optimized for cell surface expression and a conserved nucleocapsid antigen designed to be transported to the endosomal subcellular compartment.

2 Aug 2020

Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19

Now, a new study published on the preprint server medRxiv in July 2020 reports that an older treatment modality, namely, the use of convalescent antibody-rich plasma, brings down the mortality rate in hospitalized COVID-19 patients by an astonishing 57%. This adds evidence for the use of convalescent plasma in the treatment of high-risk patients.

1 Aug 2020

Vaccine News and Research

Latest Vaccine News and Research

Scientists detect emergence and spread of artemisinin-resistant malaria parasites in Rwanda

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

Study: "Memory" T cells that recognize common cold coronaviruses also recognize SARS-CoV-2

Dire COVID-19 warning from World Health Organization

New computational model can help determine drug viability

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Yale researchers develop new mouse model to study SARS-CoV-2 infection

Illustrating the dystopic nature of people’s approach to COVID-19

Study identifies possible therapeutic treatment for COVID-19

Extensive study of SARS-CoV-2 sequencing reveals six strains of the virus

Oxford University and ZOE join forces to widen access to COVID-19 treatment trials

Maternal vaccination could protect infants against RSV illness

What seniors can expect as their new normal in a post-vaccine world

Meningitis case at Children's National Hospital raises concerns about antibiotic resistance

Stabilized prefusion spike vaccine candidate induces powerful immune response

The race to a coronavirus vaccine

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in